Navigation Links
The Wellness(R) Core(R) Family Continues to Grow With New Higher Protein, Grain-Free Canned Varieties for Cats and Dogs
Date:10/30/2008

we follow the same strict guidelines for our pet food that are applied to food for people. All Wellness food and treat varieties feature recipes using human-quality ingredients without the use of meat by-products, fillers, potential allergens such as wheat (including wheat gluten) or soy, artificial colors, flavors or preservatives. Wellness is sold through knowledgeable pet specialty retailers and natural food stores in North America, and is also available internationally. For more information visit: http://www.wellnesspetfood.com.
Contacts:

Erin Vadala, Warner Communications

978/468-3076 or erin@warnerpr.com

Christen Graham, Warner Communications

207/829-6336 or christen@warnerpr.com


'/>"/>
SOURCE Wellness Natural Pet Food
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Introducing New Wellness(R) CORE(TM) Dog Ocean Formula - The Most Balanced Fish-Based Grain-Free Diet Available
2. Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees
3. Kaiser Family Foundation to Launch Non-Profit Health Policy News Service
4. Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot
5. Local Organization Receives Multi-Million Dollar Grants for Natural Family Planning, HIV Testing and Family Planning Services for Men
6. Caring.com Launches First Ad Network to Reach Family Caregivers
7. UCB Announces 2008 UCB Family RA Scholarship Program Recipients
8. National Family Partnership Designates October 27th Lock Your Meds Day
9. Save Money, Lives, and the Earth by Combining Conservation and Family Planning, Say Experts at World Conservation Congress
10. Family Income Impacts Childrens Health
11. New research on family-based HIV prevention presented at annual NIH conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:PROVERI, Inc. Named a Top Innovator Winner 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 13867 1Women Urged Not to Drink While Pregnant 56308 1Women Urged Not to Drink While Pregnant 56308 2Women Urged Not to Drink While Pregnant 56308 3Amgen to Present at the Baird Healthcare Conference 56306 1Amgen to Present at the Baird Healthcare Conference 56306 2